Anderson Stephen Charles 4/A
4/A · ONCOGENEX PHARMACEUTICALS, INC. · Filed Feb 2, 2009
Insider Transaction Report
Form 4/AAmended
Anderson Stephen Charles
CFO and Secretary
Transactions
- Award
stock option (right to buy)
2008-08-21+21,776→ 21,776 totalExercise: $4.11Exp: 2013-03-23→ Common Stock (21,776 underlying)
Footnotes (4)
- [F1]Due to administrative error, the original Form 4 overstated the exercise price by $0.0026.
- [F2]Due to an administration error, the original Form 4 understated the number of shares subject to the stock option by 13.
- [F3]16,332 shares underlying stock option were exercisable on 08/21/2008; 5,444 shares underlying stock option were exercisable on 01/09/2009.
- [F4]Received in exchange for a stock option to acquire 100,000 shares of Oncogenex Technologies Inc. ("Oncogenex Technologies") common stock for CAD$0.95 per share in connection with an arrangement between Oncogenex Technologies and Oncogenex Pharmaceuticals, Inc.